Abstract
Low 5-year survival rate in laryngeal squamous cell carcinoma (LSCC) is to large extent attributable to high rate of recurrences and metastases. Despite the importance of the latter process, its complex genetic background remains not fully understood. Recently, we identified two metastasis-related candidate genes, DIAPH2 and DIAPH3 to be frequently targeted by hemizygous/homozygous deletions, respectively, in LSCC cell lines. They physiologically regulate such processes as cell movement and adhesion, hence we found it as a rationale, to study if tumor LSCC specimens harbor mutations of these genes and whether the mutations are associated with metastasizing tumors. As a proof of concept, we sequenced both genes in five LSCC cell lines derived from lymph node metastases assuming there the highest probability of finding alterations. Indeed, we identified one hemizygous deletion (c.3116_3240del125) in DIAPH2 targeting the FH2 domain. Moreover, we analyzed 95 LSCC tumors (53 N0 and 42 N+) using the Illumina platform and identified three heterozygous single nucleotide variants in DIAPH2 targeting conserved domains exclusively in N+ tumors. By combining these results with cBioPortal data we showed significant enrichment of DIAPH2 muta...Continue Reading
References
Aug 7, 2003·Cancer Science·Hitoshi KawamataTakahiro Fujimori
May 22, 2004·BioTechniques·Richard James MeanMichael Koptides
Aug 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F LeviC La Vecchia
May 4, 2005·Molecular Cell·Takanori OtomoMichael K Rosen
May 26, 2005·Mutation Research·Marzena GajeckaKrzysztof Szyfter
Dec 13, 2006·Biophysical Journal·Tom Shemesh, Michael M Kozlov
Dec 28, 2007·Current Biology : CB·Aditya S PaulThomas Pollard
Jan 23, 2009·Molecular and Cellular Biology·Jae Ryun RyuAnn Marie Pendergast
Aug 20, 2009·Molecular Biology Reports·Katarzyna KiwerskaKrzysztof Szyfter
Apr 1, 2010·Nature Methods·Ivan A AdzhubeiShamil R Sunyaev
Jan 8, 2011·Genes, Chromosomes & Cancer·Maciej GiefingMalgorzata Jarmuz
Jan 1, 2010·Cancer Biomarkers : Section a of Disease Markers·Magdalena Kostrzewska-PoczekajKrzysztof Szyfter
Jan 17, 2012·The Journal of Biological Chemistry·Naomi Courtemanche, Thomas D Pollard
May 17, 2012·Cancer Discovery·Ethan CeramiNikolaus Schultz
May 18, 2012·EMBO Molecular Medicine·Martin H HagerMichael R Freeman
May 23, 2012·Cancer Discovery·Tsukasa ShibueRobert A Weinberg
Oct 4, 2012·Human Mutation·Hashem A ShihabTom R Gaunt
Nov 7, 2012·Nature·UNKNOWN 1000 Genomes Project ConsortiumGil A McVean
Mar 15, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayF Bray
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
Oct 26, 2013·Nature Protocols·F Ann RanFeng Zhang
Feb 4, 2014·Nature Genetics·Martin KircherJay Shendure
Mar 4, 2014·PloS One·Krista M PetteeKathryn M Eisenmann
Jan 9, 2015·G3 : Genes - Genomes - Genetics·Léna VouillotNicolas Pollet
Dec 7, 2016·Nature Communications·J C ErasmusV M M Braga
Aug 3, 2017·Journal of Surgical Oncology·Shonan ShoJames S Tomlinson
Mar 30, 2018·PloS One·Kaitlyn M DvorakKathryn M Eisenmann